RecruitingNot ApplicableNCT06059521

Software Refraction With Mobilerone Versus Retinoscopy

Randomized Controlled Study on Subjective Refraction by Software Eye Test Technology Versus Retinoscopy


Sponsor

Beijing Airdoc Technology Co., Ltd.

Enrollment

120 participants

Start Date

Jul 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.


Eligibility

Min Age: 10 YearsMax Age: 46 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing a new smartphone-based eye refraction app called Mobilerone against the traditional method (retinoscopy) used by eye doctors to measure your glasses or contact lens prescription. **You may be eligible if...** - You have a refractive error (nearsightedness, farsightedness, or astigmatism) of no more than -12.00D in each eye - Your best-corrected vision is at least 20/25 with no lazy eye (amblyopia) - You have clear, healthy eyes with no major abnormalities - You are not diabetic - You are not on medications that heavily affect vision (such as certain antimalarials or corticosteroids) **You may NOT be eligible if...** - You have a very high prescription beyond -12.00D - You have significant eye disease affecting vision clarity - You are diabetic or on vision-affecting medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESoftware refraction with Eye Test Technology in a mobilerone

Refraction is done by software App by a mobilerone software installed.

DEVICERetinoscopy

Retinoscopy is an objective refraction method with retinoscope.


Locations(3)

Airdoc MPC Opthalmology Clinics

Beijing, Beijing Municipality, China

Jenny QIU

Beijing, Beijing Municipality, China

Qiu Jenny

Beijing, Haidian District, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06059521


Related Trials